EP2707005
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.5.2012EP published:
23.8.2017EP application number:
12719993.3
EPO information:
European Patent Register
Max expiry date:
13.5.2032
Title:
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
Timeline
Today
14.5.2012EP application
23.8.2017EP Publication
Owner
Name:
CSL Behring GmbHAddress:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
Inventor
Name:
SCHULTE, StefanAddress:
Marburg, DE
Name:
KALINA, UweAddress:
Marburg, DE
Name:
MOSES, MichaelAddress:
Grävenwiesbach, DE
Name:
FEUSSNER, AnnetteAddress:
Marburg, DE
Priority
Number:
11165869Date:
12.5.2011Country:
EP
Number:
201161487205 PDate:
17.5.2011Country:
US
Classification
Categories:
A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12